Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms
New York, January 9, 2026, 13:01 EST — Regular session Immunome, Inc. shares jumped on Friday, outpacing a firmer biotech tape. The Nasdaq-listed stock (IMNM) was up 7.4% at $21.97, after trading between $20.71 and $22.00. The move keeps attention on Immunome’s lead drug, varegacestat, being developed for desmoid tumors — non-cancerous growths in connective tissue that can still be…